TY - JOUR
T1 - Use of vascular closure device is safe and effective in electrophysiological procedures
AU - Maraj, Ilir
AU - Budzikowski, Adam S.
AU - Ali, Waleed
AU - Mitre, Crisitina A.
AU - Kassotis, John
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Purpose: Little is known about the usefulness and safety of vascular closure devices (VCDs) in electrophysiological procedures. We present a retrospective analysis of our experience assessing the utility and outcomes of collagen vascular closure device (Angioseal) in patients that required periprocedural anticoagulation and multiple vascular access sites. Methods: An retrospective chart review of patients who have undergone the deployment of VCD following electrophysiological procedures. Results: In 26 patients (16 males, age 57 ± 15 years, weight 96 ± 21 kg), a total of 76 VCD were deployed. Seventy-three VCDs in femoral veins (right or left) and three in femoral artery. The mean number of VCD per patient was 3 (range, 2–4). VCD was successfully deployed in 75 out of 76 access sites. One patient was noted to have ecchymosis in both groins during follow-up visit. No other complications were noted. Conclusions: We provide evidence that a collagen plug-based VCD designed for arterial closure can be safely and effectively used to close multiple venous accesses even in the same vein. This can be accomplished with a venotomy size up to 2 Fr larger than the size of the closure device.
AB - Purpose: Little is known about the usefulness and safety of vascular closure devices (VCDs) in electrophysiological procedures. We present a retrospective analysis of our experience assessing the utility and outcomes of collagen vascular closure device (Angioseal) in patients that required periprocedural anticoagulation and multiple vascular access sites. Methods: An retrospective chart review of patients who have undergone the deployment of VCD following electrophysiological procedures. Results: In 26 patients (16 males, age 57 ± 15 years, weight 96 ± 21 kg), a total of 76 VCD were deployed. Seventy-three VCDs in femoral veins (right or left) and three in femoral artery. The mean number of VCD per patient was 3 (range, 2–4). VCD was successfully deployed in 75 out of 76 access sites. One patient was noted to have ecchymosis in both groins during follow-up visit. No other complications were noted. Conclusions: We provide evidence that a collagen plug-based VCD designed for arterial closure can be safely and effectively used to close multiple venous accesses even in the same vein. This can be accomplished with a venotomy size up to 2 Fr larger than the size of the closure device.
UR - http://www.scopus.com/inward/record.url?scp=84933670768&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84933670768&partnerID=8YFLogxK
U2 - 10.1007/s10840-015-0005-5
DO - 10.1007/s10840-015-0005-5
M3 - Article
C2 - 25921347
AN - SCOPUS:84933670768
SN - 1383-875X
VL - 43
SP - 193
EP - 195
JO - Journal of Interventional Cardiac Electrophysiology
JF - Journal of Interventional Cardiac Electrophysiology
IS - 2
ER -